Low Avidity and Level of Serum Anti-Aβ Antibodies in Patients With Cerebral Amyloid Angiopathy-Related Cerebral Hemorrhage

REFERENCES

• Du, Y., Dodel, R., Hampel, H., Buerger, K., Lin, S., Eastwood, B., (2001). Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology, 57, 801–805.
   PubMed Web of Science ®Google Scholar
• Evin, G., & Weidemann, A. (2002). Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides. Peptides, 23, 1285–1297.
   PubMed Web of Science ®Google Scholar
• Ferreira, M. U., & Katzin, A. M. (1995). The assessment of antibody affinity distribution by thiocyanate elution: A simple dose–response approach. Journal of Immunological Methods, 187, 297–305.
   PubMedGoogle Scholar
• Greenberg, S. M., & Vonsattel, J. P. (1997). Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke, 28, 1418–1422.
   PubMed Web of Science ®Google Scholar
• Han, B. H., Zhou, M. L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., (2008). Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. Journal of Neuroscience, 28, 13542–13550.
   PubMedGoogle Scholar
• Iwata, N., Takaki, Y., Fukami, S., Tsubuki, S., & Saido, T. C. (2002). Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. Journal of Neuroscience Research, 70, 493–500.
   PubMedGoogle Scholar
• Jianping, L., Zhibing, Y., Wei, Q., Zhikai, C., Jie, X., & Jinbiao, L. (2006). Low avidity and level of serum anti-Abeta antibodies in Alzheimer disease. Alzheimer Disease and Associated Disorders, 20, 127–132.
   PubMed Web of Science ®Google Scholar
• Love, S., Miners, S., Palmer, J., Chalmers, K., & Kehoe, P. (2009). Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Frontiers in Bioscience, 14, 4778–4792.
   Web of Science ®Google Scholar
• Mastaglia, F. L., Byrnes, M. L., Johnsen, R. D., & Kakulas, B. A. (2003). Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: A postmortem study. Journal of Clinical Neuroscience, 10, 186–189.
   PubMedGoogle Scholar
• McCarron, M. O., Nicoll, J. A., Ironside, J. W., Love, S., Alberts, & M. J., Bone, I. (1999). Cerebral amyloid angiopathy-related hemorrhage: Interaction of APOE epsilon2 with putative clinical risk factors. Stroke, 30, 1643–1646.
   PubMed Web of Science ®Google Scholar
• Moir, R. D., Tseitlin, K. A., Soscia, S., Hyman, B. T., Irizarry, M. C., & Tanzi, R. E. (2005). Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients. Journal of Biological Chemistry, 280, 17458–17463.
   PubMed Web of Science ®Google Scholar
• Petrushina, I., Ghochikyan, A., Mkrtichyan, M., Mamikonyan, G., Movsesyan, N., Ajdari, R., (2008). Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. Journal of Neuroinflammation, 5, 42.
   PubMedGoogle Scholar
• Pezzini, A., Del Zotto, E., Volonghi, I., Giossi, A., Costa, P., & Padovani, A. (2009). Cerebral amyloid angiopathy: A common cause of cerebral hemorrhage. Current Medicinal Chemistry, 16, 2498–2513.
   PubMedGoogle Scholar
• Pezzini, A., & Padovani, A. (2008). Cerebral amyloid angiopathy-related hemorrhages. Neurological Sciences, 29(2 Suppl.), S260–S263.
   Google Scholar
• Pullen, G. R., Fitzgerald, M. G., & Hosking, C. S. (1986). Antibody avidity determination by ELISA using thiocyanate elution. Journal of Immunological Methods, 86, 83–87.
   PubMed Web of Science ®Google Scholar
• Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., (2008). Immunotherapy reduces vascular amyloid-beta in PDAPP mice. Journal of Neuroscience, 28, 6787–6793.
   PubMed Web of Science ®Google Scholar
• Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., (2000). Clearance of Alzheimer's amyloid-ss(1–40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. Journal of Clinical Investigation, 106, 1489–1499.
   PubMed Web of Science ®Google Scholar
• Smith, E. E., & Greenberg, S. M. (2003). Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston criteria. Current Atherosclerosis Reports, 5, 260–266.
   PubMedGoogle Scholar
• Sohn, J. H., So, J. O., Kim, H., Nam, E. J., Ha, H. J., Kim, Y. H., (2007). Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice. Biochemical and Biophysical Research Communications, 361, 800–804.
   PubMedGoogle Scholar
• Thakker, D. R., Weatherspoon, M. R., Harrison, J., Keene, T. E., Lane, D. S., Kaemmerer, W. F., (2009). Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proceedings of the National Academy of Sciences of the United States of America, 106, 4501–4506.
   Google Scholar
• Thal, D. R., Griffin, W. S., de Vos, R. A., & Ghebremedhin, E. (2008). Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathologica, 115, 599–609.
   PubMed Web of Science ®Google Scholar
• Weller, R. O., Boche, D., & Nicoll, J. A. (2009). Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathologica, 118, 87–102.
   PubMed Web of Science ®Google Scholar
• Weller, R. O., & Nicoll, J. A. (2003). Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain. Neurological Research, 25, 611–616.
   PubMed Web of Science ®Google Scholar
• Weller, R. O., Preston, S. D., Subash, M., & Carare, R. O. (2009). Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimer's Research and Therapy, 1, 6.
   PubMed Web of Science ®Google Scholar
• Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O. (2008). Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathology, 18, 253–266.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nature Medicine, 9, 453–457.
   PubMed Web of Science ®Google Scholar
• Zipfel, G. J., Han, H., Ford, A. L., & Lee, J. M. (2009). Cerebral amyloid angiopathy: Progressive disruption of the neurovascular unit. Stroke, 40(3 Suppl.), S16–S19.
   Google Scholar